The U.S. Department of Health and Human Services (HHS) today issued new guidelines that require new private health plans to cover preventive services, including mammography starting at age 40.
The new guidelines state that new health plans that start on or after September 23, 2010, must cover preventive services "that have strong scientific evidence of their health benefits," an HHS statement said. In addition, these plans may no longer charge co-payments, co-insurance, or deductibles for these services when they're offered by a network provider.
HHS classifies evidence-based preventive services as those that have received a grade of A or B by the U.S. Preventive Services Task Force (USPSTF). Regarding screening mammography, the HHS announcement specifically uses the USPSTF's guidelines from 2002, which recommend that mammography screening begin at age 40; the task force's controversial guidelines from November 2009, recommending that screening begin at 50, were labeled as "not considered to be current" in the new HHS rules.
The announcement carries out provisions in the Patient Protection and Affordable Care Act passed earlier this year that were designed to support disease prevention, according to HHS.
Related Reading
HHS proposes HIPAA changes, July 9, 2010
10,000-plus in U.S. die for lack of cancer screens: CDC, July 6, 2010
Follow-ups boost mammo use among insured low-income women, June 30, 2010
Mammography screening hard-hit by economic downturn, June 22, 2010
ACR promotes VC screening bill, June 2, 2010
Copyright © 2010 AuntMinnie.com










![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)






